Platformsforsøg

Anders Perner; Maj-Brit Nørregaard Kjaer; Hans Christian Thorsen-Meyer; Benjamin Skov Kaas-Hansen; Marie W. Munch; Marie Oxenbøll-Collet; Camilla Rahbek Lysholm Bruun; Aksel Karl Georg Jensen; Theis Lange; Trine Albertsen; Claus Duedal Pedersen; Lone Musaeus Poulsen; Ole Mathiesen; Anne Craveiro Brøchner; Thomas Strøm; Lars W Andersen; Steffen Christensen; Bodil Steen Rasmussen; Olav L. Schjørring; Mathias Maagaard; Morten Hylander Møller; Anders Granholm

Platformsforsøg

Anders Perner^*, Maj-Brit Nørregaard Kjaer, Hans Christian Thorsen-Meyer, Benjamin Skov Kaas-Hansen, Marie W. Munch, Marie Oxenbøll-Collet, Camilla Rahbek Lysholm Bruun, Aksel Karl Georg Jensen, Theis Lange, Trine Albertsen, Claus Duedal Pedersen, Lone Musaeus Poulsen, Ole Mathiesen, Anne Craveiro Brøchner, Thomas Strøm, Lars W Andersen, Steffen Christensen, Bodil Steen Rasmussen, Olav L. Schjørring, Mathias MaagaardMorten Hylander Møller, Anders Granholm

^*Kontaktforfatter

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

18 Downloads (Pure)

Abstract

Platform trials focus on the perpetual testing of many interventions in a disease or a setting. These trials have lasting organizational, administrative, data, analytic, and operational frameworks making them highly efficient. The use of adaptation often increases the probabilities of allocating participants to better interventions and obtaining conclusive results. The COVID-19 pandemic showed the potential of platform trials as a fast and valid way to improved treatments. This review gives an overview of key concepts and elements using the Intensive Care Platform Trial (INCEPT) as an example.

Bidragets oversatte titel	Platform trials
Originalsprog	Dansk
Artikelnummer	V04230237
Tidsskrift	Ugeskrift for Læger
Vol/bind	186
Udgave nummer	7
Sider (fra-til)	597-600
ISSN	0041-5782
Status	Udgivet - 1. apr. 2024

Emneord

COVID-19/epidemiology
Humans
Pandemics

Dokumenter og links

Open Access VersionForlagets udgivne version, 816 KBLicens: CC BY-NC-ND

https://ugeskriftet.dk/videnskab/platformsforsogLicens: CC BY-NC-ND

Citationsformater

Perner, A., Kjaer, M.-B. N., Thorsen-Meyer, H. C., Kaas-Hansen, B. S., Munch, M. W., Oxenbøll-Collet, M., Bruun, C. R. L., Jensen, A. K. G., Lange, T., Albertsen, T., Duedal Pedersen, C., Poulsen, L. M., Mathiesen, O., Brøchner, A. C., Strøm, T., Andersen, L. W., Christensen, S., Rasmussen, B. S., Schjørring, O. L., ... Granholm, A. (2024). Platformsforsøg. Ugeskrift for Læger, 186(7), 597-600. Artikel V04230237. https://ugeskriftet.dk/videnskab/platformsforsog

@article{44ef733e110848019859a51d743fea5a,

title = "Platformsfors{\o}g",

abstract = "Platform trials focus on the perpetual testing of many interventions in a disease or a setting. These trials have lasting organizational, administrative, data, analytic, and operational frameworks making them highly efficient. The use of adaptation often increases the probabilities of allocating participants to better interventions and obtaining conclusive results. The COVID-19 pandemic showed the potential of platform trials as a fast and valid way to improved treatments. This review gives an overview of key concepts and elements using the Intensive Care Platform Trial (INCEPT) as an example.",

keywords = "COVID-19/epidemiology, Humans, Pandemics",

author = "Anders Perner and Kjaer, {Maj-Brit N{\o}rregaard} and Thorsen-Meyer, {Hans Christian} and Kaas-Hansen, {Benjamin Skov} and Munch, {Marie W.} and Marie Oxenb{\o}ll-Collet and Bruun, {Camilla Rahbek Lysholm} and Jensen, {Aksel Karl Georg} and Theis Lange and Trine Albertsen and {Duedal Pedersen}, Claus and Poulsen, {Lone Musaeus} and Ole Mathiesen and Br{\o}chner, {Anne Craveiro} and Thomas Str{\o}m and Andersen, {Lars W} and Steffen Christensen and Rasmussen, {Bodil Steen} and Schj{\o}rring, {Olav L.} and Mathias Maagaard and M{\o}ller, {Morten Hylander} and Anders Granholm",

year = "2024",

month = apr,

day = "1",

language = "Dansk",

volume = "186",

pages = "597--600",

journal = "Ugeskrift for L{\ae}ger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "7",

}

Perner, A, Kjaer, M-BN, Thorsen-Meyer, HC, Kaas-Hansen, BS, Munch, MW, Oxenbøll-Collet, M, Bruun, CRL, Jensen, AKG, Lange, T, Albertsen, T, Duedal Pedersen, C, Poulsen, LM, Mathiesen, O, Brøchner, AC , Strøm, T, Andersen, LW, Christensen, S, Rasmussen, BS, Schjørring, OL, Maagaard, M, Møller, MH & Granholm, A 2024, 'Platformsforsøg', Ugeskrift for Læger, bind 186, nr. 7, V04230237, s. 597-600. <https://ugeskriftet.dk/videnskab/platformsforsog>

TY - JOUR

T1 - Platformsforsøg

AU - Perner, Anders

AU - Kjaer, Maj-Brit Nørregaard

AU - Thorsen-Meyer, Hans Christian

AU - Kaas-Hansen, Benjamin Skov

AU - Munch, Marie W.

AU - Oxenbøll-Collet, Marie

AU - Bruun, Camilla Rahbek Lysholm

AU - Jensen, Aksel Karl Georg

AU - Lange, Theis

AU - Albertsen, Trine

AU - Duedal Pedersen, Claus

AU - Poulsen, Lone Musaeus

AU - Mathiesen, Ole

AU - Brøchner, Anne Craveiro

AU - Strøm, Thomas

AU - Andersen, Lars W

AU - Christensen, Steffen

AU - Rasmussen, Bodil Steen

AU - Schjørring, Olav L.

AU - Maagaard, Mathias

AU - Møller, Morten Hylander

AU - Granholm, Anders

PY - 2024/4/1

Y1 - 2024/4/1

N2 - Platform trials focus on the perpetual testing of many interventions in a disease or a setting. These trials have lasting organizational, administrative, data, analytic, and operational frameworks making them highly efficient. The use of adaptation often increases the probabilities of allocating participants to better interventions and obtaining conclusive results. The COVID-19 pandemic showed the potential of platform trials as a fast and valid way to improved treatments. This review gives an overview of key concepts and elements using the Intensive Care Platform Trial (INCEPT) as an example.

AB - Platform trials focus on the perpetual testing of many interventions in a disease or a setting. These trials have lasting organizational, administrative, data, analytic, and operational frameworks making them highly efficient. The use of adaptation often increases the probabilities of allocating participants to better interventions and obtaining conclusive results. The COVID-19 pandemic showed the potential of platform trials as a fast and valid way to improved treatments. This review gives an overview of key concepts and elements using the Intensive Care Platform Trial (INCEPT) as an example.

KW - COVID-19/epidemiology

KW - Humans

KW - Pandemics

M3 - Tidsskriftartikel

C2 - 37873986

AN - SCOPUS:85190853419

SN - 0041-5782

VL - 186

SP - 597

EP - 600

JO - Ugeskrift for Læger

JF - Ugeskrift for Læger

IS - 7

M1 - V04230237

ER -

Platformsforsøg

Abstract

Emneord

Dokumenter og links

Fingeraftryk

Citationsformater